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Abstract
Background—Prioritizing individual rare variants within associated genes or regions often 
consists of an ad hoc combination of statistical and biological considerations. From the statistical 
perspective, rare variants are often ranked using Fisher’s exact p values, which can lead to 
different rankings of the same set of variants depending on whether 1- or 2-sided p values are 
used.
Results—We propose a likelihood ratio-based measure, maxLRc, for the statistical component of 
ranking rare variants under a case-control study design that avoids the hypothesis-testing 
paradigm. We prove analytically that the maxLRc is always well-defined, even when the data has 
zero cell counts in the 2×2 disease-variant table. Via simulation, we show that the maxLRc 
outperforms Fisher’s exact p values in most practical scenarios considered. Using next-generation 
sequence data from 27 rolandic epilepsy cases and 200 controls in a region previously shown to be 
linked to and associated with rolandic epilepsy, we demonstrate that rankings assigned by the 
maxLRc and exact p values can differ substantially.
Conclusion—The maxLRc provides reliable statistical prioritization of rare variants using only 
the observed data, avoiding the need to specify parameters associated with hypothesis testing that 
can result in ranking discrepancies across p value procedures; and it is applicable to common 
variant prioritization.
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Introduction
It is well appreciated that the single-marker analysis approach, which has been successful in 
identifying common disease-associated variants in genome-wide association studies, has 
limited power to detect association with rare variants (minor allele frequency, MAF, <5%). 
To increase statistical power, various methods have been proposed to combine genetic 
information across multiple rare variants within a gene or region of interest [1–9]. While 
these ‘combined methods’ have been shown to be effective as a first step in detecting 
associated regions, the ultimate goal is localizing individual causal variants within the 
identified regions that directly affect disease presentation. There is limited statistical 
literature addressing the difficult task of fine mapping amongst rare variants within 
previously detected associated genes or regions. Ionita-Laza et al. [10] proposed a sliding-
window approach to scan genes or regions of interest to further detect causal rare variant-
enriched sub-regions. A similar sliding-window-based method was also published by 
Brisbin et al. [11]. However, as with any initial identification of associated regions of 
interest, fine mapped subregions may still include a large number of individual rare variants 
that require further refinement. For example, in Ionita-Laza et al. [10], the authors applied 
one of the combined methods, the variable threshold approach [4], in autism spectrum 
disorder and identified two significantly associated genes, one of which spans an ~235-kb 
region on chromosome 2. Even with further fine mapping, the significantly associated sub-
region covers a 26-kb region. Therefore, in order to select the most promising variants for 
follow-up biological experiments, further prioritization on the individual variant level is 
necessary and statistical information can assist with this additional refinement.
The most commonly implemented approach to prioritize individual variants in case-control 
studies is to rank them based on p values. For rare variants specifically, Fisher’s exact p 
values are often computed since low MAFs can lead to sparse and skewed data. However, 
the computation of Fisher’s exact p values requires the investigator to choose whether the p 
values will be 1- or 2-sided, and which 2-sided method to implement. The p value rankings 
for the same set of rare variants can differ substantially across these choices, due to the 
asymmetry of the discrete hypergeometric distribution underlying Fisher’s exact test. 
Therefore, two investigators with different beliefs or knowledge of the direction of 
association may select different rare variants for follow-up based on statistical 
considerations, a problem that we encountered when deciding how to prioritize rare 
sequence variants from a linkage region in a study of rolandic epilepsy (see Materials and 
Methods).
Although prior information such as expert opinions, biological knowledge or findings from 
previous studies may improve prioritization, results heavily depend on what type of prior 
information is used and how this information is incorporated into the prioritization. 
Therefore, a prioritization method based solely on the observed data and independent of a-
priori beliefs on the direction of association could provide a common objective starting point 
from which to work.
The evidential paradigm (EP) [12–15], an alternative to Frequentist and Bayesian paradigms 
for statistical inference, uses likelihood ratios (LRs) to measure statistical evidence in a 
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given body of data and does not require one to specify hypothesis-testing characteristics or 
prior probability distributions. The evidential paradigm has favorable operational 
characteristics, where interpreting evidence via the LR for two simple hypotheses will not 
lead one to favor an incorrect hypothesis with high probability [16–18], i.e. P0 (LR > k) for 
k > 1, referred to as the probability of misleading evidence, M, is bounded by 1/k. The EP 
has been applied to genetic linkage and association studies [17–20], and here we propose an 
EP method to prioritize rare variants within an associated region. The calculation of the LR 
as a measure of evidence in the EP requires the specification of two simple hypothesized 
values for the parameter of interest, e.g. a null and an alternative value. While the null value 
is often chosen to represent no difference, for example, no association or no linkage, many 
strategies are available to choose the alternative value depending on the study context. In 
clinical trials, the alternative value can be chosen to represent the minimum clinically 
important difference, or a 2-fold change in studies of differential gene expression [14]. For 
prioritization in a region of association, choice of a simple alternative across all markers in 
the region is not obvious. The maximum likelihood estimator, the parameter value that is 
best supported by the data, would be a convenient choice, although the probability of 
misleading evidence M is not bounded [14] when the LRs are constructed using the 
maximum likelihood estimator as the alternative value. However, when the goal of the study 
is to prioritize variants within an associated region, one is less concerned with elevated 
probabilities of falsely observing evidence for association versus none. Here we define new 
operational characteristics tailored to variant prioritization.
Motivated by the EP, we introduce a LR-based measure, maxLRc, for ranking rare variants 
that does not require one to specify a direction of association or choose among multiple 
methods to compute 2-sided exact p values. Distinct from the combined methods that are 
designed to detect associated genes or regions, our goal here is to provide an objective 
measure of the strength of statistical evidence to use for prioritizing individual rare variants 
within an associated region. We show analytically that the maxLRc is based on the same 
underlying model as Fisher’s exact test. Via simulation, we show that 1-sided Fisher’s exact 
p values, calculated assuming the same directions of effect for all variants, performed 
substantially worse than 2-sided exact p values and the max-LRc, unless all causal variants 
are simulated with the same directions of effects. In addition, we show that the max-LRc 
outperforms 2-sided Fisher’s exact p values in most simulation settings.
Materials and Methods
With a case-control study design, a 2×3 contingency table can be constructed to compare 
genotype frequencies in cases and controls at each rare variant. Due to the low MAF, the 
probability of observing the homozygous genotype for the minor allele is extremely low, 
and it is customary to collapse the data into a 2×2 table by case-control status and presence 
or absence of the minor allele.
Maximum Conditional Likelihood Ratio
We propose to rank rare sequence variants using a LR-based measure, the maxLRc. Let Yi 
denote the case-control status for a random sample of i = 1, …, N individuals, with Yi = 1 
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for cases and Yi = 0 for controls, and Xi, a dichotomous variable with Xi = 1 for carriers of 
the minor allele and Xi = 0 for non-carriers. Assuming a logistic regression model, logit {P 
(Yi = 1)} = β0 + β1 X1, the parameter of interest is β1, the log odds ratio, which measures the 
effect of the rare variant on the case-control status. In a logistic regression model, the 
exposures are regarded as fixed quantities while the case-control status is considered 
random. Although in a typical genetic association study design, subjects are selected based 
on their case-control status, the logistic model provides correct estimates of β1 invariant to 
study design [21]. So here we consider the number of carriers and non-carriers of the minor 
allele, denoted by n1 and n2, respectively, as fixed under the logistic regression model. For a 
2×2 table, let
reflect the total number of cases and
the total number of cases who carry the minor allele (table 1). Then the full likelihood of the 
observed data is given by
To re-express the likelihood as a function of β1 alone, we condition the full likelihood on the 
sufficient statistic for β0, t0, and the resulting conditional likelihood has the following form
Note that conditioning on the sufficient statistic t0 is equivalent to fixing the total number of 
cases and, in turn, the total number of controls. Since the number of carriers and non-carriers 
are also fixed under the model assumption, both margins of the 2×2 table are considered 
fixed. This is the same assumption underlying Fisher’s exact test, and therefore, the 
conditional likelihood has exactly the same formulation as Fisher’s non-central 
hypergeometric distribution. Let  denote the maximum conditional likelihood estimate 
of the odds ratio. We define
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and we propose the simple idea of prioritizing rare sequence variants by the maxLRc. 
Essentially, the maxLRc contrasts the conditional likelihood at the odds ratio value that is 
best supported by the data and the value of 1, representing no association. Fully specifying 
the conditional likelihood, we have
Similar to the unconditional likelihood estimate of the odd ratio,  does not always exist 
for 2×2 tables. In general, 2×2 contingency tables can be classified into three cases [22] : (1) 
complete separation, where the two cell counts in the main- or off-diagonal of the 2×2 table 
equal zero; (2) quasi-complete separation, where only one of the four cell counts is zero, and 
(3) overlap, in which case there is no zero cell in the table. While the  always exists in 
the overlap case, it is not well-defined when data is in complete or quasi-complete 
separation, i.e.  or ∞; however, we show analytically that the maxLRc remains 
well-defined in these two cases, and it is equal to
The above result shows that in the two separation cases, the max-LRc is equivalent to the 
inverse of the hypergeometric probability of the observed 2×2 table.
Fisher’s 2-Sided Exact p Value
In the hypothesis testing framework, 1-sided tests may be appropriate and more powerful 
than 2-sided tests if additional information on the directions of association is known and 
correct. However, such information is rarely available for all causal and nearby variants in a 
region of interest. One strategy is to assume the same effect for all variants in a region [9]; 
however, such an assumption can lead to substantially inferior ranking performance, as 
observed in our simulations (see online suppl. table S1; see www.karger.com/doi/
10.1159/000371579 for all online suppl. material). Therefore, we focus on comparisons of 
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prioritization performance between the maxLRc and 2-sided Fisher’s exact p values. There 
are many strategies to compute 2-sided p values for Fisher’s exact test, each with its own 
advantages and drawbacks. Among these methods, the most popular and widely 
implemented method is the ‘minimum likelihood’ approach. In this approach, 2-sided 
Fisher’s exact p value is calculated by summing up the probabilities of all possible tables 
with the same margins as the observed one, whose associated probabilities are less than or 
equal to the probability of the observed table. We use this minimum likelihood approach 
here.
Simulation Study
We performed extensive simulations to empirically compare the prioritization performance 
between the maxLRc and 2-sided Fisher’s exact p value. We considered the number of cases 
to be 100, 150, 200, 250, 500 and 1,000, with a control:case ratio of 1, 1.5 and 2, for a total 
of 18 sample size combinations. For each sample size (N), we simulated a total of 100 rare 
variants, among which, the number of truly associated rare variants, Q, was set to be 10 or 
20. Each rare variant, regardless of causal or null, was generated with a MAF randomly 
selected from the uniform (0.005, 0.05) distribution. For truly associated variants, we first 
considered the scenario where the directions of effect were randomly assigned as positive or 
negative, and therefore, the proportion of deleterious or protective variants was not fixed. 
We then considered the scenario where 80% of the truly associated variants have deleterious 
effects. The effect sizes, ∣β1∣, for the Q truly associated variants ranged from 0.41 to 2.5, 
corresponding to odd ratios of 1.5–10.5 for deleterious variants or 1/10.5–1/1.5 for 
protective variants. All variants were simulated under Hardy-Weinberg equilibrium and all 
null variants were simulated assuming an underlying odds ratio of 1. Due to the low MAF, 
rare variants usually do not show strong linkage disequilibrium with each other [23, 24], and 
therefore, all variants were simulated independently of each other. For each set of parameter 
values, we repeated the simulation 1,000 times.
Prioritization Performance Comparison
The comparisons between the maxLRc and Fisher’s exact p values were based on three 
metrics: (1) Kendall’s correlation between the ‘true’ ranking underlying the simulation and 
the ranking assigned by the maxLRc or Fisher’s exact p values; (2) the number of truly 
associated (NT) variants among the K selected, where K is a pre-specified number of 
variants to be selected for follow-up, and we considered all integer values of K ranging from 
1 to 50, and (3) the average ranking of the collection of truly associated variants.
To evaluate (1), we only used the set of truly associated variants, and the ‘true’ ranking was 
defined by the ordering of the absolute values of the underlying effect sizes ∣β1∣. Here, a 
larger Kendall’s correlation coefficient indicates better agreement with the ‘true’ ranking. 
For (2), we considered the scenario where there are limited resources and only K variants 
are to be followed-up, and we compared the NT variants in the K selected according to 
rankings assigned by the maxLRc or Fisher’s exact p values. At each value of K considered, 
we plotted the median of the 1,000 NT values (obtained from the 1,000 repetitions) 
according to the maxLRc or Fisher’s exact p values (NT plot). To compare the overall 
ranking performance, we summed up NT over all values of K, here denoting this sum by 
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sumK, and a larger sumK value indicates better overall performance. In (3), for each 
repetition, we calculated the average ranking of the truly associated variants assigned by 
each of the maxLRc and exact p values, and we then compared the means of the 1,000 
averages.
In addition, we used simulations to compare the performance of the maxLRc and 2-sided 
Fisher’s exact p value under the same sample size configuration as in our motivating study 
of rolandic epilepsy [26]. Specifically, we simulated rare variants with 27 cases and 200 
controls, Q = 10 and randomly assigned directions of association.
Prioritizing Rare Variants in a Study of Rolandic Epilepsy
We illustrate how rankings assigned by the maxLRc and 2-sided Fisher’s exact p value 
could differ substantially for the same set of rare variants using next-generation sequence 
data from a rolandic epilepsy study. Rolandic epilepsy is the most common epilepsy 
syndrome in childhood [25], and it is linked to and associated with a 600-kb region on 
chromosome 11 [26]. To prioritize individual rare variants within this region, we used next-
generation sequence data from 27 rolandic epilepsy cases sequenced on the Illumina GAIIX 
platform, and an independent sample of 200 individuals ascertained for a study of colorectal 
cancer whole-genome sequenced by complete genomics and made available to us as a 
control group [27]. After standard quality control analysis, 207 rare variants with a MAF 
<5% remained for the prioritization. We then ranked the 207 rare variants based on both 
maxLRc and 2-sided Fisher’s exact p value.
Results
When ranking with 1-sided Fisher’s exact p values, if the directions of effect for all causal 
variants are randomly assigned or fixed at 80% positive, 1-sided Fisher’s exact p value 
performs substantially worse than the maxLRc and 2-sided Fisher’s exact p value. Only 
when all causal variants are simulated to have positive effect and 1-sided p values are 
calculated in the positive direction, do they outperform the other two methods (see online 
suppl. table S1).
We now focus on ranking performance comparisons between the maxLRc and 2-sided 
Fisher’s exact p values and present results from simulations generated with an equal number 
of cases and controls, although results for other control:case ratios are similar. The mean 
Kendall’s correlation coefficients, averaged over the 1,000 repetitions, are presented in table 
2 for the scenarios where Q = 10 and in online supplementary table S2 for Q = 20. In all 
cases, rankings assigned by the maxLRc are in better agreement with the underlying ‘true’ 
rankings, as indicated by a higher mean Kendall’s correlation.
NT plots for simulations with Q = 10 are provided in figures 1 and 2; and those with Q = 20 
are provided in online supplementary figures S1 and S2. When the directions of association 
are randomly assigned, the maxLRc selects more or an equal number of truly associated 
variants than 2-sided Fisher’s exact p value for a given K in almost all cases. When the 
majority (80%) of the truly associated variants have deleterious effect, the maxLRc performs 
better or worse depending on the value of K; however, it has a better overall performance, as 
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indicated by a larger sumK value, in all sample size configurations except when the sample 
size is small (at N = 200; see online suppl. tables S3 and S4).
The means of the average rankings of the collection of truly associated variants are 
summarized in table 3 and online suppl. table S5 for Q = 10 and Q = 20, respectively. The 
means of the average rankings of the collection of all causal variants are smaller using the 
maxLRc than 2-sided Fisher’s exact p value in all cases considered; i.e. on average, the truly 
associated variants are always collectively ranked higher by the maxLRc. The results from 
simulations with control:case ratios of 1.5 and 2 are similar to those presented above (data 
not shown).
Analysis of the rare variants identified in a 600-kb region linked to and associated with 
rolandic epilepsy illustrated ranking discrepancies between the maxLRc and 2-sided Fisher’s 
exact p value. The top ten ranked variants by the maxLRc, together with their corresponding 
rankings by 2-sided Fisher’s exact p values, are provided in table 4. It is evident that the two 
methods can prioritize this set of variants differently, disagreeing even on the top ranked 
variant. The ranking discrepancies can be substantial, for example, rs1806176, which is 
ranked 5th by the maxLRc, is ranked 12th by the p value approach. Simulation results 
suggest that the maxLRc outperforms 2-sided Fisher’s exact p value under similar sample 
sizes, with Kendall’s correlation coefficient = 0.31 and 0.23, sumK = 269 and 244 and 
average ranking of the collection of Q = 26.37 and 29.69, for the maxLRc and 2-sided 
Fisher’s exact p value, respectively.
Discussion
The maxLRc does as good or outperforms 2-sided Fisher’s exact p value in prioritizing rare 
variants in most cases that we considered. Across all simulation scenarios, rankings assigned 
by the maxLRc correlate better with the underlying true rankings, and the collection of all 
causal variants is always ranked higher by the max-LRc. When only a few variants are to be 
selected for follow-up, i.e. K is very small, the two methods perform similarly regardless of 
sample size; and as sample size gets large, the two methods are expected to have equivalent 
performance. The difference between the two methods fundamentally lies in how they 
measure the strength of statistical evidence. The maxLRc is based on the distribution of the 
data in the observed 2×2 table, whereas 2-sided Fisher’s exact p values further incorporate 
the probability of more extreme tables that could have been observed. Which values are to 
be defined as more extreme depends on whether the investigator is conducting a 1-sided or 
2-sided test, a choice the EP approach does not require.
In constructing the maxLRc, we chose to use conditional likelihood for several reasons. 
First, it allows for elimination of the nuisance parameter β0. It also ensures that the maxLRc 
is always well-defined, even in the two separation cases. This property does not hold if a 
maximized LR is constructed from estimated or profile likelihoods. Finally, the derivation of 
the conditional likelihood requires the same assumption as Fisher’s exact test, which 
excludes the possibility that the two methods perform differently simply due to different 
model assumptions.
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The maxLRc is a conditional LR. Therefore, 2 × log (maxLRc) follows a χ2 distribution 
with 1 degree of freedom asymptotically, under fairly general regularity conditions [28]. 
This implies that we could calculate asymptotic p values based on the maxLRc despite 
having sparse data, and the prioritization of variants based on this asymptotic p value would 
coincide with the rankings provided by the maxLRc. Computing asymptotic p values in the 
sparse data setting would, of course, be contrary to recommended standard statistical 
practice from a hypothesis testing perspective.
Although we proposed the maxLRc for rare variant prioritization, this method is applicable 
to common variants as well, without requiring the genotype categories being collapsed into 
minor allele carrier status (details in the Appendix). In addition, the method of conditioning 
on sufficient statistics, which forms the basis of exact conditional logistic regression [29], 
can be used to eliminate multiple nuisance parameters providing a theory for including 
covariates in the calculation of the maxLRc. However, as the sample size and number of 
covariates increase, the computational burden becomes prohibitive for practical applications. 
In such cases, profile likelihood could be used instead of conditional likelihood to maintain 
computational efficiency.
In summary, the maxLRc provides reliable statistical prioritization of sequence variants and 
outperforms the standard method of prioritizing by Fisher’s exact p values in the majority of 
settings we considered. Although the difference in some cases was minimal, using the 
maxLRc to prioritize variants avoids the need to make arbitrary decisions about hypothesis 
testing parameters such as whether to compute 1- or 2-sided p values, and which 2-sided p 
value to compute. Moreover, the computational time is equivalent for the maxLRc and 
Fisher’s exact p values, making it an attractive and easy to implement alternative. The 
maxLRc is applicable to both rare and common variants and can be easily implemented in R 
[30], with R code available at strug.research.sick-kids.ca.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Appendix
Derivation of the maxLRc under the Quasi-Complete and Complete 
Separation Cases
When a 2×2 table is under complete or quasi-complete separation (see table A1 for 
examples), the maximum conditional likelihood estimate of the odd ratio, , is equal to 
∞ (table A1a–c) or 0 (table A1d–f). Without loss of generality, we provide the proof below 
for the case where .
where
by Vandermonde’s identity.
Computing the maxLRc for Common Variants
Let Yi = 1 or 0 represent the case-control status, and Xi = 0, 1 or 2 denote the number of 
minor alleles that subject i carries, therefore, assuming an additive genetic effect. For easier 
representation, let us further define n1, n2 and n3 as the number of subjects carrying 0, 1 or 2 
copies of the minor allele and r1, r2 and r3 as the number of cases carrying 0, 1 or 2 copies of 
the minor allele, respectively. The sufficient statistic for β0 is
the total number of cases; and the sufficient statistic for β1 is
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The conditional likelihood for the data, as a function of β1 alone, is then
Where Γ includes all possible combinations of  such that  and 
.
The maxLRc is then given by
with  representing the maximum conditional likelihood estimate of β1.
Table A1
Example 2 × 2 tables under complete separation (a and d) or quasi-complete separation (b, c, 
e and f); A, B, C, D > 0
Carrier Non-carrier Carrier Non-carrier Carrier Non-carrier
a b c
Case A 0 Case A 0 Case A B
Control 0 C Control C D Control 0 D
d e f
Case 0 B Case A B Case 0 B
Control C 0 Control C 0 Control C D
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Fig. 1. 
NT plots for rare variants simulated with MAF ∈ [0.005, 0.05], Q = 10 and randomly 
assigned directions of effect. For all sample size configurations, the maxLRc uniformly 
selected more or an equal number of truly associated variants than 2-sided Fisher’s exact p 
value across all values of K.
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Fig. 2. 
NT plots for rare variants simulated with MAF ∈ [0.005, 0.05], Q = 10 and with 80% of the 
casual variants having deleterious effect. For all sample size configurations, the maxLRc 
selected more or an equal number of truly associated variants than 2-sided Fisher’s exact p 
value in most cases.
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Table 1
An example of a 2 × 2 contingency table classified by disease status and minor allele carrier status
Carrier of
minor allele
Non-carrier of
minor allele
Case t1 t0 – t1 t0
Control n1 – t1 n2 – t0 + t1 n1 + n2 – t0
n1 n2 N
Hum Hered. Author manuscript; available in PMC 2016 February 19.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Li et al. Page 17
Table 2
Mean Kendall’s correlation coefficients
Sample size 100 variants (10 causal, 90 null)
randomly assigned
direction of effect
8 deleterious and 2
protective effects
maxLRc 2-sided Fisher’sp value max LRc
2-sided Fisher’s
p value
100:100 0.39 0.35 0.48 0.46
150:150 0.42 0.40 0.51 0.49
200:200 0.43 0.41 0.53 0.51
250:250 0.43 0.41 0.55 0.54
500:500 0.47 0.46 0.58 0.57
1,000:1,000 0.50 0.50 0.59 0.59
Kendall’s correlation coefficients were calculated across 1,000 repetitions, for rare variants generated with a MAF ∈ [0.005, 0.05], Q = 10 and an 
equal number of cases and controls. The direction of effect is given for the causal variants.
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Table 3
Mean of the average rankings of the collection of truly associated variants
Sample size 100 variants (10 causal, 90 null)
randomly assigned
direction of effect
8 deleterious and 2
protective effect
maxLRc 2-sided Fisher’sp value maxLRc
2-sided Fisher’s
p value
100:100 19.32 20.63 16.71 16.87
150:150 16.97 18.19 14.59 14.89
200:200 15.25 16.28 13.23 13.55
250:250 13.42 14.27 11.75 12.09
500:500 9.64 10.04 8.62 8.79
1,000:1,000 7.16 7.30 6.79 6.87
The average rankings were calculated across 1,000 repetitions, for rare variants generated with MAF ∈ [0.005, 0.05], Q = 10 and an equal number 
of cases and controls. The direction of effect is given for the causal variants
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Table 4
Prioritization of rare sequence variants from 27 rolandic epilepsy cases and 200 colorectal cancer controls
Chr Variant Base-pairposition MAF maxLRc
2-sided Fisher’s
exact p value
Ranking by
maxLRc 2-sided Fisher’sp value
11 rs6484529 31,724,195 0.003 189 0.0053 1 2
11 rs180775607 31,463,255 0.005 88.08 0.0114 2 4
11 rs11031419 31,605,896 0.028 55.83 0.0052 3 1
11 rs558508 31,800,907 0.029 34.49 0.0081 4 3
11 rs1806176 31,842,323 0.017 28.71 0.0348 5 12
11 rs78174119 31,735,627 0.020 23.10 0.0133 6 5
11 rs4359181 31,759,404 0.033 18.21 0.0154 7 6
11 rs182818125 31,388,793 0.007 17.61 0.0265 8 8
11 rs182363098 31,565,443 0.007 17.61 0.0265 8 8
11 31393303 31,393,303 0.007 16.15 0.0290 10 10
The top ten rare variants, ranked by the maxLRc, are shown together with their corresponding rankings assigned by 2-sided Fisher’s exact p value.
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